Literature DB >> 33160565

ChAdOx1 nCoV-19 vaccine for SARS-CoV-2 - Authors' reply.

Merryn Voysey1, Andrew J Pollard2.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 33160565     DOI: 10.1016/S0140-6736(20)32267-4

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  1 in total

1.  Comparative effectiveness and safety of homologous two-dose ChAdOx1 versus heterologous vaccination with ChAdOx1 and BNT162b2.

Authors:  Eduardo Hermosilla; Ermengol Coma; Junqing Xie; Shuo Feng; Carmen Cabezas; Leonardo Méndez-Boo; Francesc Fina; Elisabet Ballo; Montserrat Martínez; Manuel Medina-Peralta; Josep Maria Argimon; Daniel Prieto-Alhambra
Journal:  Nat Commun       Date:  2022-03-23       Impact factor: 14.919

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.